December 2016

We have completed phase 1 of our study with the GC376 protease inhibitor. This study is being done in collaboration with colleagues at Kansas State University.   We have been inundated with requests from owners around the world to have their cats treated, many on the presumption that we have a cure Read more…

We are currently almost two months into a field trial to test the efficacy of a protease inhibitoragainst 13 cats with naturally occurring FIP of wet, dry and mixed types with and withoutneurologic disease. The trial has been closed at this time to allow us time to study this initialgroup Read more…